The Lancet Gastroenterology & Hepatology in conversation with
Health & Fitness:Medicine
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
2022-11-09
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.
Read the full article:
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More Episodes
2020-01-17
2020-01-14
2019-11-27
2019-09-12
2019-08-28
2019-07-30
2019-07-17
2019-05-23
2019-05-11
2019-04-05
2019-03-08
2019-02-08
2018-12-07
2018-09-06
2018-08-10
Get this podcast on your
phone, FREE
